M. Figini et al., EVIDENCE THAT TACHYKININS RELAX THE GUINEA-PIG TRACHEA VIA NITRIC-OXIDE RELEASE AND BY STIMULATION OF A SEPTIDE-INSENSITIVE NK1 RECEPTOR, British Journal of Pharmacology, 117(6), 1996, pp. 1270-1276
1 This study investigated the possibility that tachykinins relax the g
uinea-pig isolated trachea by releasing nitric oxide (NO) from the epi
thelium. The types of tachykinin receptor mediating both relaxation an
d contraction of the trachea were also studied. Isometric tension was
recorded in isolated tracheal tube preparations precontracted with ace
tylcholine (10 mu M) in which compounds were administered intraluminal
ly in the presence of phosphoramidon and indomethacin (both 1 mu M) an
d the tachykinin NK2 receptor antagonist, SR 48,968 ((S)-N-methyl-N[4-
(4-acetyl iperidino)-2-(3,4-dichlorophenyl)butyl]benzamide), 0.1 mu M)
. 2 In the presence of the inactive enantiomer of an NO-synthase inhib
itor, N-G-monomethyl-D-arginine (D-NMMA, 100 mu M), substance P (SP),
neurokinin A (NKA), neurokinin B (NKB) and the selective NK1 receptor
agonist, [Sar(9), Met(O-2)(11)]-SP, (0.1-10 nM) relaxed tracheal tube
preparations. This relaxation was changed into a contraction by pretre
atment with the NO-synthase inhibitor, N-G-monomethyl-L-arginine (L-NM
MA, 100 mu M). The effect of L-NMMA on SP- and [Sar(9), Met(O-2)(11)]-
SP-induced responses was reversed by L-arginine (L-Arg, 1 mM), but not
by D-Arg (1 mM). After removal of the epithelium SP, NKA and NKB and
[Sar(9), Met(O-2)(11)]-SP (0.1-10 nM) evoked contractile responses in
the presence of either L-NMMA (100 mu M) or D-NMMA (100 mu M). The eff
ects of SP and [Sar(9), Met(O-2)(11)]-SP obtained in the presence of a
nother NO-synthase inhibitor, N-G-nitro-L-arginine methyl ester (L-NAM
E, 100 mu M) or its inactive enantiomer, N-G-nitro-D-arginine methyl e
ster (D-NAME, 100 mu M) were similar to those observed with L-NMMA or
D-NMMA, respectively. 3 The selective NK1 receptor agonist, [pGlu(6),
Pro(9)]-SP(6-11) (septide, 0.1-10 nM) evoked contractile responses of
tracheal tube preparations in the presence of either D-NMMA (100 mu M)
or L-NMMA (100 mu M). The log concentration-response curve to septide
obtained in the presence of L-NMMA was similar to that obtained in th
e presence of D-NMMA. [Sar(9), Met(O-2)(11)]-SP (0.1-10 nM) relaxed tr
acheal tube preparations precontracted with septide (1 mu M), whereas
septide (0.1 nM-1 mu M) further contracted tracheal tube preparations
precontracted with [Sar(9), Met(O-2)(11)]-SP (1 mu M). 4 Relaxant and
contractile responses evoked by SP, NKA, NKB and by [Sar(9), Met(O-2)(
11)]-SP (0.1-10 nM) were not affected by a combination of the histamin
e H-1 (pyrilamine, 1 mu M) and H-2 (cimetidine, 1 mu M) receptor antag
onists, but were abolished by the tachykinin NK1 receptor antagonist,
CP-99,994 2S,3S)-3-(2-methoxybenzylamino)-2-phenylpiperidine 1 mu M),
though not by its inactive enantiomer CP-100,263 (1 mu M). Contractile
responses evoked by septide (10 nM and 1 mu M) were also abolished by
CP-99,994 (1 mu M) but not by CP-100,263 (1 mu M). 5 These results de
monstrate that tachykinins relax guinea-pig tracheal tube preparations
by releasing NO via the stimulation of epithelial NK1 receptors by a
mechanism independent of histamine release. The NK1 receptor type invo
lved is sensitive to SP, NKA, NKB and [Sar(9), Met(O-2)(11)]-SP but no
t to septide, and is pharmacologically distinct from the NK1 receptor
that mediates contraction, which is stimulated by all the agonists, in
cluding septide.